Free Trial
NYSE:ZEPP

Zepp Health (ZEPP) Stock Price, News & Analysis

$0.76
+0.03 (+4.10%)
(As of 05/31/2024 ET)
Today's Range
$0.73
$0.80
50-Day Range
$0.73
$1.02
52-Week Range
$0.70
$2.10
Volume
101,796 shs
Average Volume
78,957 shs
Market Capitalization
$45.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.19

Zepp Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
581.8% Upside
$5.19 Price Target
Short Interest
Healthy
0.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.02mentions of Zepp Health in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.27 out of 5 stars

Medical Sector

640th out of 928 stocks

Electronic Computers Industry

6th out of 6 stocks

ZEPP stock logo

About Zepp Health Stock (NYSE:ZEPP)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

ZEPP Stock Price History

ZEPP Stock News Headlines

Zepp Health Q1 2024 Earnings Preview
See More Headlines
Receive ZEPP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
6/01/2024
Next Earnings (Estimated)
8/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electronic computers
Sub-Industry
N/A
Fax
N/A
Employees
839
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.19
High Stock Price Target
$5.19
Low Stock Price Target
$5.19
Potential Upside/Downside
+581.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-29,880,000.00
Pretax Margin
-8.19%

Debt

Sales & Book Value

Annual Sales
$351.46 million
Book Value
$5.57 per share

Miscellaneous

Free Float
38,532,000
Market Cap
$45.83 million
Optionable
Optionable
Beta
0.88
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Wang Huang (Age 48)
    Founder, Chairman & CEO
  • Mr. Leon Cheng Deng (Age 41)
    Chief Financial Officer
  • Mr. Mike Yan Yeung (Age 53)
    Chief Operating Officer
  • Mr. Meihui Fan (Age 45)
    Chief Technology Officer
  • Ms. Grace Yujia Zhang
    Director of Investor Relations
  • Mr. Pengtao Yu (Age 42)
    Chief Industrial Designer
  • Dr. Ramesh Jain Ph.D.
    Chief Technical Advisor of Huami AI Research Institute

ZEPP Stock Analysis - Frequently Asked Questions

Should I buy or sell Zepp Health stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zepp Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ZEPP shares.
View ZEPP analyst ratings
or view top-rated stocks.

What is Zepp Health's stock price target for 2024?

1 equities research analysts have issued twelve-month price targets for Zepp Health's shares. Their ZEPP share price targets range from $5.19 to $5.19. On average, they expect the company's share price to reach $5.19 in the next year. This suggests a possible upside of 581.8% from the stock's current price.
View analysts price targets for ZEPP
or view top-rated stocks among Wall Street analysts.

How have ZEPP shares performed in 2024?

Zepp Health's stock was trading at $1.42 on January 1st, 2024. Since then, ZEPP shares have decreased by 46.4% and is now trading at $0.7612.
View the best growth stocks for 2024 here
.

Are investors shorting Zepp Health?

Zepp Health saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 23,400 shares, an increase of 28.6% from the April 30th total of 18,200 shares. Based on an average daily trading volume, of 73,300 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.1% of the shares of the company are short sold.
View Zepp Health's Short Interest
.

When is Zepp Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 19th 2024.
View our ZEPP earnings forecast
.

How were Zepp Health's earnings last quarter?

Zepp Health Co. (NYSE:ZEPP) released its earnings results on Monday, March, 18th. The company reported ($0.02) EPS for the quarter. The business had revenue of $84.47 million for the quarter. Zepp Health had a negative trailing twelve-month return on equity of 7.24% and a negative net margin of 8.45%.

What guidance has Zepp Health issued on next quarter's earnings?

Zepp Health issued an update on its second quarter 2024 earnings guidance on Tuesday, May, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $40.0 million-$55.0 million, compared to the consensus revenue estimate of $72.5 million.

How do I buy shares of Zepp Health?

Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ZEPP) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners